CytoMed Therapeutics Ltd
GDTC · Pharmaceutical Preparations
Latest available SEC filing: 4/A ·
Latest disclosures
-
Choo Chee Kong: Form 4/A
Insider disclosure · Filed · Report period 14 Jul 2026
-
Form 4
SEC filing · Filed
-
Form 4/A
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 3
SEC filing · Filed
-
Form 3
SEC filing · Filed
-
Form 3
SEC filing · Filed
-
Latest financial period: Q4 2025
Financial facts · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- GDTC · Y1R80M106 - Ordinary Shares
Company details and SEC sources
CIK 0001873093 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- GDTC on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- #08 22 One Commonwealth, 1 Commonwealth Lane, Singapore, 149544
- Incorporated in
- Singapore
- Fiscal year end
- 31 December
- Former names on EDGAR
- CytoMed Therapeutics Pte. Ltd. (to 30 Nov 2022)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields